CPWM
OGN icon

Cypress Point Wealth Management’s Organon & Co OGN Stock Holding History

Cypress Point Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12
Closed – – 197
2021
Q2 		$0 Buy
+12
New +$395 ﹤0.01% 200

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cypress Point Wealth Management's OGN Position: Q3 2021 in Review

Cypress Point Wealth Management sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 12 shares.

Cypress Point Wealth Management first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 927 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • Cypress Point Wealth Management reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
  • Cypress Point Wealth Management sold 12 Organon & Co shares in Q3 2021.
  • Cypress Point Wealth Management first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
  • Cypress Point Wealth Management's Organon & Co position peaked at $0 in Q2 2021.
  • 927 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Cypress Point Wealth Management's 13F filing for Q3 2021, filed 5 Nov 2021.